Despite substantial progress in the development of antiretroviral regimens that durably
suppress Human Immunodeficiency Virus (HIV) infection, new agents that maintain high …

Prior research suggests that stigma plays a role in racial/ethnic health disparities. However,
there is limited understanding about the mechanisms by which stigma contributes to HIV …

Objectives Life expectancy is an important indicator informing decision making in policies
relating to HIV‐infected people. Studies estimating life expectancy after starting combination …

Background Combination antiretroviral therapy (ART) has significantly increased survival
among HIV-positive adults in the United States (US) and Canada, but gains in life …

Background. Human immunodeficiency virus (HIV)-associated neurocognitive disorders
(HAND) can show variable clinical trajectories. Previous longitudinal studies of HAND …

Although antiretroviral therapy for HIV infection prevents AIDS-related complications and
prolongs life, it does not fully restore health. Long-term treated patients remain at higher than …

HIV risk behaviors, susceptibility to HIV acquisition, progression of disease after infection,
and response to antiretroviral therapy all vary by age. In those living with HIV, current …

Background Few estimates exist of the life expectancy of HIV-positive adults receiving
antiretroviral treatment (ART) in low-and middle-income countries. We aimed to estimate the …

Life expectancy living with HIV: recent estimates and future... : Current Opinion in Infectious
Diseases Life expectancy living with HIV: recent estimates and future implications : Current …

Objectives To estimate life expectancy for people with HIV undergoing treatment compared
with life expectancy in the general population and to assess the impact on life expectancy of …